In silico identification of five binding sites on the SARS-CoV-2 spike protein and selection of seven ligands for such sites
Description
To contribute to the development of products capable of complexing with the SARS-CoV-2 spike protein, and thus preventing the virus from entering the host cell, this work aimed at discovering binding sites in the whole protein structure, as well as